12 completed, 3 recruiting, 2 unknown, 1 not yet recruiting. 5 Not applicable, 2 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Candida Infection: new trials by email Literature Review of Candida Infection trials Research Report on Candida Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biofilm Formation and Antifungal Resistance in Candida Species Candida Infection | Not yet recruiting | Assiut University | 300 | 2025-12-20 | 2025-11-24 | |
| Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes Non-interventional study - Vulvovaginitis, Candidal, Vulvovaginal Candidiasis | Recruiting | GlaxoSmithKline | 100 | 2025-11-12 | 2026-09-23 | |
| One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to go Candida Infection | Recruiting | University Hospital, Strasbourg, France | 16 | 2025-05-28 | 2025-12-24 | |
| Analysis of Candida-Associated Osteoarticular Infections: Multicenter Turkish Data Candida Osteomyelitis, Candida Infection | Completed | Kocaeli University | 73 | 2024-12-05 | 2025-04-24 | |
| Oropharyngeal Candidiasis (OPC) and S-ECC Candida Infection, Oral Thrush | Recruiting | Temple University | 70 | 2024-09-01 | 2026-06-22 | |
| Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement CanXida Remove (Formula RMV), Placebo - Candida Systemic, Candida Albicans Infection | Not applicable | Completed | CanXida | 60 | 2023-11-30 | 2024-08-22 |
| Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp Ibrexafungerp - Vulvovaginal Candidiasis, Candida Infection | Phase 1 | Completed | Scynexis, Inc. | 5 | 2023-07-12 | 2025-08-08 |
| Mucormycosis in COVID-19 Covid19, Mucormycosis | Completed | Montefiore Medical Center | 728 | 2021-05-24 | 2023-04-18 | |
| HIV Indicator Diseases in Hospital and Primary Care Peer to peer feedback, HIV rapid test - HIV Infections, Primary Health Care | Unknown | Erasmus Medical Center | 1500 | 2020-01-01 | 2022-02-04 | |
| An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris APX001 - Candidemia, Invasive Candidiases | Phase 2 | Completed | Basilea Pharmaceutica | 9 | 2019-12-13 | 2025-09-16 |
| Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients collection of blood samples - Candida Infection | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 50 | 2019-05-14 | 2023-02-13 | |
| The Anti-microbial Effect of Titanium Dioxide Nano Particles in Complete Dentures Made for Edentulous Patients Titanium Dioxide Nanoparticles - Candida Infection, Denture Stomatitis | Not applicable | Unknown | Cairo University | 20 | 2018-10-15 | 2018-09-11 |
| Ampholipad Real-World Data in Taiwan Aspergillus Infection, Febrile Neutropenia | Completed | Taiwan Liposome Company | 102 | 2018-09-09 | 2021-01-07 | |
| Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation To evaluate the initial levels and kinetics of serum β-D-glucan - Peritonitis Infectious, Candida Infection | Not applicable | Completed | Centre Hospitalier Universitaire, Amiens | 70 | 2018-05-01 | 2025-09-19 |
| Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. Disinfection Protocol - Candidiasis, Biofilms | Not applicable | Completed | University of Sao Paulo | 108 | 2014-09-01 | 2017-07-02 |
| Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida Medium-Chain Triglyceride (MCT) Oil - Candida Infection, Premature Infant | Phase 1 | Completed | Joseph Bliss | 12 | 2014-06-05 | 2022-06-14 |
| The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus Probiotic lactobacilli reuteri, Nystatin, fluocinolone - Oral Lichen Planus, Candida Infection | Not applicable | Completed | University of Copenhagen | 25 | 2012-03-01 | 2015-12-11 |
| Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients Nystatin - Fungal Prophylaxis, Candida Infection | Phase 4 | Completed | Policlinico Hospital | 99 | 2008-11-01 | 2017-04-05 |
Candidiasis (18) · Candidiasis, Oral (3) · Aspergillosis (2) · Candidiasis, Invasive (2) · Candidiasis, Vulvovaginal (2) · Mycoses (2) · Torulopsis (2) · Acquired Immunodeficiency Syndrome (1) · Arthritis (1) · COVID-19 (1) · Candidemia (1) · Critical Illness (1) · Dermatitis, Seborrheic (1) · Discitis (1) · Febrile Neutropenia (1)
Bacterial Infections and Mycoses (18) · Infections (18) · Mycoses (16) · Mouth Diseases (5) · Stomatognathic Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (4) · Urogenital Diseases (4) · Female Urogenital Diseases (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cytopenia (2) · Disease Attributes (2) · Hematologic Diseases (2)
Nystatin (2) · Oils (1) · fluocinolone (1) · ibrexafungerp (1)
Assiut University (1) · Basilea Pharmaceutica (1) · Cairo University (1) · CanXida (1) · Centre Hospitalier Universitaire, Amiens (1) · Erasmus Medical Center (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · GlaxoSmithKline (1) · Joseph Bliss (1) · Kocaeli University (1) · Montefiore Medical Center (1) · Policlinico Hospital (1) · Scynexis, Inc. (1) · Taiwan Liposome Company (1) · Temple University (1)
United States (5) · France (2) · Italy (2) · Denmark (1) · India (1) · Netherlands (1) · South Africa (1) · Taiwan (1) · Turkey (Türkiye) (1)
Carl Brown, PhD (1) · Filomena Puntillo, Professor (1) · Francesco Bruno, Professor (1) · Joseph M Bliss, MD, PhD (1) · Marc Engelhardt (1) · Mette K Keller, PhD (1) · Yuan Liu, DDS, MS, PhD (1)
PMID 22490643, PMID 29596218, PMID 35628743, PMID 37022196, PMID 39731054